skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.10e (Release date: 2017-10-30)
SearchBox Top
SearchBox Bottom
Picibanil (Code C745)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Picibanil

Definition: A lyophilized formulation containing cultures of a low-virulent strain of Streptococcus pyogenes, treated and killed with pencillin G, with potential sclerosing, immunostimulating and antineoplastic activity. Besides from picibanil's direct damaging effect as a sclerosing agent, it seems to have multiple effects on the immune system as a non-specific immunostimulant. Picibanil activates the host immune system by stimulating the activity of natural killer cells, macrophages and lymphocytes, and by enhancing the production of several key immune mediators, including interleukins and tumor necrosis factor.

Label: Picibanil

NCI Thesaurus Code: C745 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0031875  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)

External Source Codes: 
CAS Registry Number 39325-01-4 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 489137
PDQ Open Trial Search ID 489137 (check for NCI PDQ open clinical trial info)
UMLS CUI C0031875

Other Properties:
     Name Value (qualifiers indented underneath)
code C745
Contributing_Source FDA
Legacy_Concept_Name OK-432
Semantic_Type Organic Chemical
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom